Literature DB >> 30275047

Lysyl-Transfer RNA Synthetase Induces the Maturation of Dendritic Cells through MAPK and NF-κB Pathways, Strongly Contributing to Enhanced Th1 Cell Responses.

Hui Xuan Lim1, Hak-Jun Jung1, Arim Lee1, Si Hoon Park1, Byung Woo Han2, Daeho Cho3, Tae Sung Kim4.   

Abstract

In addition to essential roles in protein synthesis, lysyl-tRNA synthetase (KRS) is secreted to trigger a proinflammatory function that induces macrophage activation and TNF-α secretion. KRS has been associated with autoimmune diseases such as polymyositis and dermatomyositis. In this study, we investigated the immunomodulatory effects of KRS on bone marrow-derived dendritic cells (DCs) of C57BL/6 mice and subsequent polarization of Th cells and analyzed the underlying mechanisms. KRS-treated DCs increased the expression of cell surface molecules and proinflammatory cytokines associated with DC maturation and activation. Especially, KRS treatment significantly increased production of IL-12, a Th1-polarizing cytokine, in DCs. KRS triggered the nuclear translocation of the NF-κB p65 subunit along with the degradation of IκB proteins and the phosphorylation of MAPKs in DCs. Additionally, JNK, p38, and ERK inhibitors markedly recovered the degradation of IκB proteins, suggesting the involvement of MAPKs as the upstream regulators of NF-κB in the KRS-induced DC maturation and activation. Importantly, KRS-treated DCs strongly increased the differentiation of Th1 cells when cocultured with CD4+ T cells. The addition of anti-IL-12-neutralizing Ab abolished the secretion of IFN-γ in the coculture, indicating that KRS induces Th1 cell response via DC-derived IL-12. Moreover, KRS enhanced the OVA-specific Th1 cell polarization in vivo following the adoptive transfer of OVA-pulsed DCs. Taken together, these results indicated that KRS effectively induced the maturation and activation of DCs through MAPKs/NF-κB-signaling pathways and favored DC-mediated Th1 cell response.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30275047     DOI: 10.4049/jimmunol.1800386

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  MHC class I and II peptide homology regulates the cellular immune response.

Authors:  Matthew M Halpert; Vanaja Konduri; Dan Liang; Jonathan Vazquez-Perez; Colby J Hofferek; Scott A Weldon; Yunyu Baig; Indira Vedula; Jonathan M Levitt; William K Decker
Journal:  FASEB J       Date:  2020-04-16       Impact factor: 5.191

2.  Effect of Selenium and Peroxynitrite on Immune Function of Immature Dendritic Cells in Humans.

Authors:  Huan Xia; Liangliang Zhang; Jie Dai; Xianmei Liu; Xin Zhang; Zhu Zeng; Yi Jia
Journal:  Med Sci Monit       Date:  2021-03-08

3.  GVS-12 attenuates non-alcoholic steatohepatitis by suppressing inflammatory responses via PPARγ/STAT3 signaling pathways.

Authors:  Yuhui Wang; Xiyang Zhang; Bo Yuan; Xi Lu; Dongxuan Zheng; Kefeng Zhang; Mingli Zhong; Xiaotian Xu; Xiaoqun Duan
Journal:  RSC Adv       Date:  2019-03-26       Impact factor: 3.361

4.  Threonyl-tRNA Synthetase Promotes T Helper Type 1 Cell Responses by Inducing Dendritic Cell Maturation and IL-12 Production via an NF-κB Pathway.

Authors:  Hak-Jun Jung; Su-Ho Park; Kyung-Min Cho; Kwang Il Jung; Daeho Cho; Tae Sung Kim
Journal:  Front Immunol       Date:  2020-10-14       Impact factor: 7.561

5.  Genome-wide association study implicates novel loci and reveals candidate effector genes for longitudinal pediatric bone accrual.

Authors:  Diana L Cousminer; Yadav Wagley; James A Pippin; Ahmed Elhakeem; Gregory P Way; Matthew C Pahl; Shana E McCormack; Alessandra Chesi; Jonathan A Mitchell; Joseph M Kindler; Denis Baird; April Hartley; Laura Howe; Heidi J Kalkwarf; Joan M Lappe; Sumei Lu; Michelle E Leonard; Matthew E Johnson; Hakon Hakonarson; Vicente Gilsanz; John A Shepherd; Sharon E Oberfield; Casey S Greene; Andrea Kelly; Deborah A Lawlor; Benjamin F Voight; Andrew D Wells; Babette S Zemel; Kurt D Hankenson; Struan F A Grant
Journal:  Genome Biol       Date:  2021-01-04       Impact factor: 13.583

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.